November 20, 2022
3 thousand watches
Williams says he served on an independent data monitoring committee for GlaxoSmithKline and on a scientific advisory board for Quidel.
NEW YORK – In this video taken on Infectious diseases in children forum, John W. Williams, MD, describes a variety of interventions in development against respiratory viral infections, which are currently on the rise in the United States.
According to Williams, these include newer, longer-lasting monoclonal antibodies and many late-stage vaccine candidates.
Williams, who is chief of pediatric infectious diseases at UPMC Children’s Hospital of Pittsburgh and director of the Institute for Infection, Inflammation and Immunity in Children (i4Kids), said it is “likely” there will be an RSV vaccine licensed for older adults. and pregnant people “within the next year or so.”
“This is very exciting for us as pediatricians because we’ve really lacked tools against RSV for far too long,” Williams said.
Williams JV. Keynote Presentation: Preview of Upcoming Attraction: RSV Prevention. Presented at: Infectious diseases in children Forum; Nov. 19-20, 2022; New York (hybrid meeting).